(Q43218781)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20014902%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20014902%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

Helicobacter pylori infectious disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20014902%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Ivan Mitov

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20014902%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Ivan Mitov

series ordinal

2

1 reference

16 November 2017

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20014902%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20014902%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20014902%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20014902%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

59-70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20014902%20AND%20SRC:MED&resulttype=core&format=json

Helicobacter pylori detection and antimicrobial susceptibility testing

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

H pylori antibiotic resistance: prevalence, importance, and advances in testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

New concepts of resistance in the treatment of Helicobacter pylori infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Prevalence of multidrug-resistant Helicobacter pylori in Bulgaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

High frequency of gastric colonization with multiple Helicobacter pylori strains in Venezuelan subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Helicobacter pylori amoxicillin heteroresistance due to point mutations in PBP-1A in isogenic isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Clarithromycin resistance in Helicobacter pylori strains isolated from French children: prevalence of the different mutations and coexistence of clones harboring two different mutations in the same biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

A redox basis for metronidazole resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Resistance mechanisms in an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Amoxicillin resistance with beta-lactamase production in Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

16S rRNA mutations that confer tetracycline resistance in Helicobacter pylori decrease drug binding in Escherichia coli ribosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998–2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Evaluation of clinical and socio-demographic risk factors for antibacterial resistance of Helicobacter pylori in Bulgaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Antibiotic-resistant Helicobacter pylori strains in Portuguese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Cultural recovery and determination of antimicrobial susceptibility in Helicobacter pylori by using commercial transport and isolation media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

High Helicobacter pylori resistance rate to clarithromycin in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Primary resistance in Helicobacter pylori isolated in children from Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Antimicrobial drug use and resistance in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Helicobacter pylori: bacteriological aspects, diagnostic methods, and susceptibility to antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Furazolidone therapy for Helicobacter pylori: is it effective and safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Quinolone resistance in Helicobacter pylori isolates in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Fluorescence in situ hybridization vs. epsilometer test for detection of clarithromycin-susceptible and clarithromycin-resistant Helicobacter pylori strains in gastric biopsies from children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Finnish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

High prevalence and level of resistance to metronidazole, but lack of resistance to other antimicrobials in Helicobacter pylori, isolated from a multiracial population in Kuwait

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.113

21 January 2018

Identifiers

DOI

10.1586/ERI.09.113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20014902%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference